SCHEMBL8098865

SCHEMBL8098865

COCCN1CCC(n2cc(-c3cccc(O)c3)c3c(N)ncnc32)C1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 19/20 0.76
EGFR P00533 18/20 0.76
SRC P12931 18/20 0.76
ABL2 P42684 17/20 0.76
LCK P06239 8/20 0.72
JAK2 O60674 3/20 0.65
INSR P06213 3/20 0.65
RET P07949 3/20 0.65
IGF1R P08069 3/20 0.65
KIT P10721 3/20 0.65
PDGFRA P16234 3/20 0.65
FGFR4 P22455 3/20 0.65
FGFR3 P22607 3/20 0.65
KDR P35968 3/20 0.65
ALK Q9UM73 3/20 0.65
NTRK1 P04629 2/20 0.65
NPM1 P06748 2/20 0.65
CSF1R P07333 2/20 0.65
LYN P07948 2/20 0.65
MET P08581 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8108060 0.95 ABL1 (0.80) ABL1EGFRSRCABL2LCK
SCHEMBL8107232 0.90 ABL1 (0.78) ABL1EGFRSRCABL2LCK
SCHEMBL7023786 0.89 ABL1 (0.89) ABL1EGFRSRCABL2LCK
SCHEMBL8108098 0.89 SRC (0.62) ABL1EGFRSRCABL2LCK
SCHEMBL8098878 0.89 SRC (0.63) ABL1EGFRSRCABL2LCK
SCHEMBL7021411 0.86 ABL1 (1.00) ABL1EGFRSRCABL2LCK
SCHEMBL7015822 0.86 ABL1 (0.77) ABL1EGFRSRCABL2LCK
SCHEMBL7021099 0.85 ABL1 (0.75) ABL1EGFRSRCABL2LCK
SCHEMBL7019164 0.84 ABL1 (1.00) ABL1EGFRSRCABL2LCK
SCHEMBL8107295 0.84 EGFR (0.86) ABL1EGFRSRCABL2LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6051577-A TYROSINE INHIBITORS; BONE DISORDERS NOVARTIS AG (CH) 2000-04-18 US disclosed